Your English writing platform
Discover LudwigSuggestions(1)
Exact(17)
The approvals will solidify Biogen's position as a leader in multiple sclerosis drugs.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Biogen last week said it would pay $55 million to settle a dispute with Schering's Berlex Laboratories Inc. over patents for multiple sclerosis drugs.
BOSTON (Reuters) — Biogen Idec said on Wednesday its fourth-quarter profit rose 84percenttoppinging expectations, driven by increased sales of its multiple sclerosis drugs Avonex and Tysabri.
Biogen, itself the product of a merger, is known for its multiple sclerosis drugs Avonex and Tysabri and the cancer drug Rituxan.
Mr. Icahn wants Biogen, the world's biggest maker of multiple sclerosis drugs, to reduce costs and improve relationships with its partners.
Similar(43)
The company's strong start was driven by increased sales of its multiple sclerosis drug, Rebif.
Biogen needs Amevive to relieve its dependence on a single product, the multiple sclerosis drug Avonex.
The company attributed the increase primarily to sales of Novantrone, a multiple sclerosis drug it began marketing in March.
[C4.] A panel of the Food and Drug Administration will discuss about whether to allow a multiple sclerosis drug back on the market.
The multiple sclerosis drug Tysabri was hurt by new cases of a rare brain infection, called progressive multifocal leukoencephalopathy.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com